Lifecore Biomedical Inc
NASDAQ:LFCR

Watchlist Manager
Lifecore Biomedical Inc Logo
Lifecore Biomedical Inc
NASDAQ:LFCR
Watchlist
Price: 7.6 USD 8.11% Market Closed
Market Cap: 279.9m USD
Have any thoughts about
Lifecore Biomedical Inc?
Write Note

Lifecore Biomedical Inc
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lifecore Biomedical Inc
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Lifecore Biomedical Inc
NASDAQ:LFCR
Tax Provision
-$70k
CAGR 3-Years
51%
CAGR 5-Years
37%
CAGR 10-Years
39%
Hershey Co
NYSE:HSY
Tax Provision
-$296.9m
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
4%
General Mills Inc
NYSE:GIS
Tax Provision
-$637.5m
CAGR 3-Years
-2%
CAGR 5-Years
-11%
CAGR 10-Years
1%
Kellogg Co
NYSE:K
Tax Provision
-$177m
CAGR 3-Years
24%
CAGR 5-Years
5%
CAGR 10-Years
14%
Kraft Heinz Co
NASDAQ:KHC
Tax Provision
-$673m
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mondelez International Inc
NASDAQ:MDLZ
Tax Provision
-$1.5B
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
-18%
No Stocks Found

Lifecore Biomedical Inc
Glance View

Market Cap
279.9m USD
Industry
Food Products

Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.

LFCR Intrinsic Value
10.95 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is Lifecore Biomedical Inc's Tax Provision?
Tax Provision
-70k USD

Based on the financial report for Aug 25, 2024, Lifecore Biomedical Inc's Tax Provision amounts to -70k USD.

What is Lifecore Biomedical Inc's Tax Provision growth rate?
Tax Provision CAGR 10Y
39%

Over the last year, the Tax Provision growth was 83%. The average annual Tax Provision growth rates for Lifecore Biomedical Inc have been 51% over the past three years , 37% over the past five years , and 39% over the past ten years .

Back to Top